You really would @LibbyA. I know the drug companies have approached the government repeatedly but have been knocked back every time.
My understanding is that of everyone diagnosed with BC, there is a group that clearly need to have chemotherapy, and a group that clearly don't. However in between there's a group in a grey area. In a large study done recently, they worked out that using genomic tests only 30% of that group actually need to have chemo.
If the 70% who are currently having chemo 'unnecessarily' didn't have it, you'd think that it would save the health budget more than the subsidised genomic tests would cost. It would also save a lot of unnecessary suffering, and the cost of managing the ongoing side effects that many are left with.
I find it all very frustrating.